nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CA6—submandibular gland—periodontitis	0.0493	0.122	CbGeAlD
Nilotinib—MAPK8—periosteum—periodontitis	0.0328	0.0811	CbGeAlD
Nilotinib—CA6—saliva—periodontitis	0.0177	0.0438	CbGeAlD
Nilotinib—CSF1R—periosteum—periodontitis	0.0151	0.0373	CbGeAlD
Nilotinib—Imatinib—NTRK1—periodontitis	0.0139	1	CrCbGaD
Nilotinib—MAPK8—endothelium—periodontitis	0.0121	0.0299	CbGeAlD
Nilotinib—TIE1—endothelium—periodontitis	0.0105	0.0259	CbGeAlD
Nilotinib—EPHA4—tongue—periodontitis	0.00957	0.0236	CbGeAlD
Nilotinib—MAPK8—mouth—periodontitis	0.00934	0.0231	CbGeAlD
Nilotinib—CA2—periosteum—periodontitis	0.00812	0.0201	CbGeAlD
Nilotinib—MAPK8—neck—periodontitis	0.00799	0.0197	CbGeAlD
Nilotinib—CDC42BPB—trigeminal ganglion—periodontitis	0.00762	0.0188	CbGeAlD
Nilotinib—EPHB4—endothelium—periodontitis	0.00729	0.018	CbGeAlD
Nilotinib—TEK—endothelium—periodontitis	0.00697	0.0172	CbGeAlD
Nilotinib—CA6—mouth—periodontitis	0.00671	0.0166	CbGeAlD
Nilotinib—EPHA4—mouth—periodontitis	0.00643	0.0159	CbGeAlD
Nilotinib—CA3—mouth—periodontitis	0.00635	0.0157	CbGeAlD
Nilotinib—MAPK14—mouth—periodontitis	0.00593	0.0146	CbGeAlD
Nilotinib—MAPK8—connective tissue—periodontitis	0.00572	0.0141	CbGeAlD
Nilotinib—EPHB3—trigeminal ganglion—periodontitis	0.00569	0.014	CbGeAlD
Nilotinib—MAPK8—epithelium—periodontitis	0.00543	0.0134	CbGeAlD
Nilotinib—LYN—connective tissue—periodontitis	0.00528	0.013	CbGeAlD
Nilotinib—HCK—trigeminal ganglion—periodontitis	0.00523	0.0129	CbGeAlD
Nilotinib—MAPK14—neck—periodontitis	0.00507	0.0125	CbGeAlD
Nilotinib—KIT—endothelium—periodontitis	0.00505	0.0125	CbGeAlD
Nilotinib—TIE1—epithelium—periodontitis	0.00471	0.0116	CbGeAlD
Nilotinib—CA6—parotid gland—periodontitis	0.00467	0.0115	CbGeAlD
Nilotinib—CA3—parotid gland—periodontitis	0.00442	0.0109	CbGeAlD
Nilotinib—LCK—trigeminal ganglion—periodontitis	0.00436	0.0108	CbGeAlD
Nilotinib—EPHB4—trigeminal ganglion—periodontitis	0.00415	0.0102	CbGeAlD
Nilotinib—EPHA2—trigeminal ganglion—periodontitis	0.00407	0.0101	CbGeAlD
Nilotinib—TEK—trigeminal ganglion—periodontitis	0.00397	0.00981	CbGeAlD
Nilotinib—EPHB4—parotid gland—periodontitis	0.00392	0.00967	CbGeAlD
Nilotinib—KIT—mouth—periodontitis	0.0039	0.00962	CbGeAlD
Nilotinib—CA3—connective tissue—periodontitis	0.00389	0.00961	CbGeAlD
Nilotinib—EPHA2—parotid gland—periodontitis	0.00384	0.00948	CbGeAlD
Nilotinib—EPHB6—trigeminal ganglion—periodontitis	0.0038	0.00937	CbGeAlD
Nilotinib—MAPK14—connective tissue—periodontitis	0.00363	0.00897	CbGeAlD
Nilotinib—EPHB6—parotid gland—periodontitis	0.00358	0.00884	CbGeAlD
Nilotinib—MAPK14—epithelium—periodontitis	0.00345	0.00852	CbGeAlD
Nilotinib—EPHB4—connective tissue—periodontitis	0.00345	0.00851	CbGeAlD
Nilotinib—KIT—neck—periodontitis	0.00333	0.00823	CbGeAlD
Nilotinib—TEK—connective tissue—periodontitis	0.0033	0.00814	CbGeAlD
Nilotinib—EPHB4—epithelium—periodontitis	0.00327	0.00808	CbGeAlD
Nilotinib—PDGFRB—neck—periodontitis	0.00325	0.00804	CbGeAlD
Nilotinib—MAP2K5—trigeminal ganglion—periodontitis	0.00325	0.00802	CbGeAlD
Nilotinib—EPHA2—epithelium—periodontitis	0.00321	0.00792	CbGeAlD
Nilotinib—CSF1R—trigeminal ganglion—periodontitis	0.00317	0.00782	CbGeAlD
Nilotinib—TEK—epithelium—periodontitis	0.00313	0.00773	CbGeAlD
Nilotinib—MAP2K5—parotid gland—periodontitis	0.00306	0.00756	CbGeAlD
Nilotinib—PDGFRA—connective tissue—periodontitis	0.00299	0.00738	CbGeAlD
Nilotinib—KIT—trigeminal ganglion—periodontitis	0.00288	0.0071	CbGeAlD
Nilotinib—PDGFRB—trigeminal ganglion—periodontitis	0.00281	0.00694	CbGeAlD
Nilotinib—CA12—connective tissue—periodontitis	0.00276	0.00681	CbGeAlD
Nilotinib—KIT—parotid gland—periodontitis	0.00271	0.0067	CbGeAlD
Nilotinib—PDGFRB—parotid gland—periodontitis	0.00265	0.00654	CbGeAlD
Nilotinib—CSF1R—connective tissue—periodontitis	0.00263	0.00649	CbGeAlD
Nilotinib—ABL1—trigeminal ganglion—periodontitis	0.0025	0.00618	CbGeAlD
Nilotinib—KIT—connective tissue—periodontitis	0.00239	0.0059	CbGeAlD
Nilotinib—CA4—neck—periodontitis	0.00238	0.00588	CbGeAlD
Nilotinib—ABL1—parotid gland—periodontitis	0.00236	0.00583	CbGeAlD
Nilotinib—PDGFRB—connective tissue—periodontitis	0.00233	0.00576	CbGeAlD
Nilotinib—CA2—mouth—periodontitis	0.00231	0.0057	CbGeAlD
Nilotinib—KIT—epithelium—periodontitis	0.00227	0.0056	CbGeAlD
Nilotinib—PDGFRB—epithelium—periodontitis	0.00221	0.00547	CbGeAlD
Nilotinib—ABL1—connective tissue—periodontitis	0.00208	0.00513	CbGeAlD
Nilotinib—CA2—neck—periodontitis	0.00198	0.00488	CbGeAlD
Nilotinib—CA4—parotid gland—periodontitis	0.00194	0.00479	CbGeAlD
Nilotinib—CA2—trigeminal ganglion—periodontitis	0.00171	0.00421	CbGeAlD
Nilotinib—CA2—parotid gland—periodontitis	0.00161	0.00397	CbGeAlD
Nilotinib—ABCG2—trigeminal ganglion—periodontitis	0.00158	0.0039	CbGeAlD
Nilotinib—ABCG2—parotid gland—periodontitis	0.00149	0.00368	CbGeAlD
Nilotinib—CA2—connective tissue—periodontitis	0.00142	0.0035	CbGeAlD
Nilotinib—CA2—epithelium—periodontitis	0.00134	0.00332	CbGeAlD
Nilotinib—ABCB1—trigeminal ganglion—periodontitis	0.000779	0.00192	CbGeAlD
Nilotinib—ABCB1—epithelium—periodontitis	0.000614	0.00152	CbGeAlD
Nilotinib—LYN—Developmental Biology—MMP9—periodontitis	4.49e-05	7.73e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—AGER—periodontitis	4.49e-05	7.72e-05	CbGpPWpGaD
Nilotinib—HCK—Disease—PTGS2—periodontitis	4.48e-05	7.7e-05	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—MMP9—periodontitis	4.47e-05	7.7e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CXCR2—periodontitis	4.47e-05	7.69e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL1A—periodontitis	4.46e-05	7.67e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CRP—periodontitis	4.45e-05	7.67e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL18—periodontitis	4.45e-05	7.65e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—IL6—periodontitis	4.41e-05	7.59e-05	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—IL6—periodontitis	4.39e-05	7.56e-05	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—IL6—periodontitis	4.37e-05	7.51e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—NOS2—periodontitis	4.35e-05	7.49e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—VCAM1—periodontitis	4.35e-05	7.48e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCR2—periodontitis	4.33e-05	7.45e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—ADRB1—periodontitis	4.31e-05	7.42e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—AGER—periodontitis	4.27e-05	7.35e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—TLR4—periodontitis	4.27e-05	7.35e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MMP3—periodontitis	4.27e-05	7.35e-05	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—MMP9—periodontitis	4.26e-05	7.33e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCR2—periodontitis	4.24e-05	7.3e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MMP3—periodontitis	4.23e-05	7.28e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—ADRB1—periodontitis	4.22e-05	7.27e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NTRK1—periodontitis	4.14e-05	7.12e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—FGF2—periodontitis	4.11e-05	7.07e-05	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—IL6—periodontitis	4.11e-05	7.07e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GGT1—periodontitis	4.1e-05	7.05e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—IL6—periodontitis	4.1e-05	7.05e-05	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—IL6—periodontitis	4.09e-05	7.05e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL1B—periodontitis	4.09e-05	7.03e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL1B—periodontitis	4.09e-05	7.03e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL1B—periodontitis	4.07e-05	7.01e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCR2—periodontitis	4.02e-05	6.92e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CRP—periodontitis	4.01e-05	6.91e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—ADRB1—periodontitis	4e-05	6.89e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—NOS2—periodontitis	3.96e-05	6.82e-05	CbGpPWpGaD
Nilotinib—CA4—Metabolism—PTGS2—periodontitis	3.96e-05	6.82e-05	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—FGF2—periodontitis	3.95e-05	6.79e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.94e-05	6.78e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CRP—periodontitis	3.93e-05	6.76e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NTRK1—periodontitis	3.92e-05	6.74e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CRP—periodontitis	3.91e-05	6.73e-05	CbGpPWpGaD
Nilotinib—LYN—Axon guidance—IL6—periodontitis	3.91e-05	6.73e-05	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—IL6—periodontitis	3.89e-05	6.7e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—FGF2—periodontitis	3.88e-05	6.68e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ACP5—periodontitis	3.88e-05	6.67e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1A—periodontitis	3.85e-05	6.63e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MMP3—periodontitis	3.85e-05	6.62e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—TLR4—periodontitis	3.85e-05	6.62e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL18—periodontitis	3.85e-05	6.62e-05	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—PPARA—periodontitis	3.82e-05	6.57e-05	CbGpPWpGaD
Nilotinib—CA2—Metabolism—PTGS2—periodontitis	3.8e-05	6.53e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—TLR4—periodontitis	3.77e-05	6.48e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NOS2—periodontitis	3.75e-05	6.45e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—TLR4—periodontitis	3.75e-05	6.45e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CRP—periodontitis	3.72e-05	6.41e-05	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—IL6—periodontitis	3.71e-05	6.38e-05	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TGFB1—periodontitis	3.7e-05	6.37e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—AGER—periodontitis	3.69e-05	6.36e-05	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TGFB1—periodontitis	3.69e-05	6.34e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IFNG—periodontitis	3.65e-05	6.28e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MMP3—periodontitis	3.64e-05	6.27e-05	CbGpPWpGaD
Nilotinib—CA1—Metabolism—PTGS2—periodontitis	3.64e-05	6.27e-05	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—TGFB1—periodontitis	3.63e-05	6.25e-05	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—TGFB1—periodontitis	3.62e-05	6.22e-05	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—IL6—periodontitis	3.6e-05	6.2e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—TLR4—periodontitis	3.57e-05	6.15e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—FGF2—periodontitis	3.55e-05	6.11e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—IL6—periodontitis	3.54e-05	6.09e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SLC52A3—periodontitis	3.53e-05	6.08e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NTRK1—periodontitis	3.53e-05	6.08e-05	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TGFB1—periodontitis	3.51e-05	6.04e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—FGF2—periodontitis	3.5e-05	6.02e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CCL2—periodontitis	3.48e-05	5.99e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GGT1—periodontitis	3.48e-05	5.98e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCR2—periodontitis	3.48e-05	5.98e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	3.47e-05	5.97e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ADRB1—periodontitis	3.46e-05	5.95e-05	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TNF—periodontitis	3.46e-05	5.95e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NTRK1—periodontitis	3.46e-05	5.95e-05	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—TGFB1—periodontitis	3.44e-05	5.93e-05	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TNF—periodontitis	3.44e-05	5.92e-05	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	3.4e-05	5.85e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NOS2—periodontitis	3.38e-05	5.81e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ACP5—periodontitis	3.38e-05	5.81e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CCL2—periodontitis	3.31e-05	5.7e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—FGF2—periodontitis	3.31e-05	5.7e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IFNG—periodontitis	3.29e-05	5.66e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MMP3—periodontitis	3.28e-05	5.65e-05	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TNF—periodontitis	3.28e-05	5.64e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NTRK1—periodontitis	3.28e-05	5.64e-05	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—IL6—periodontitis	3.27e-05	5.63e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL1B—periodontitis	3.26e-05	5.6e-05	CbGpPWpGaD
Nilotinib—HCK—Disease—TGFB1—periodontitis	3.24e-05	5.57e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—FGF2—periodontitis	3.23e-05	5.56e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CRP—periodontitis	3.22e-05	5.54e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MMP3—periodontitis	3.21e-05	5.53e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—PTGS2—periodontitis	3.2e-05	5.51e-05	CbGpPWpGaD
Nilotinib—CA9—Metabolism—PTGS2—periodontitis	3.2e-05	5.51e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ACP5—periodontitis	3.18e-05	5.48e-05	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	3.17e-05	5.46e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ACP5—periodontitis	3.16e-05	5.43e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—FGF2—periodontitis	3.15e-05	5.42e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IFNG—periodontitis	3.12e-05	5.36e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—TLR4—periodontitis	3.09e-05	5.31e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—FGF2—periodontitis	3.06e-05	5.26e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MMP3—periodontitis	3.05e-05	5.24e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—FGF2—periodontitis	2.99e-05	5.15e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—FGF2—periodontitis	2.98e-05	5.13e-05	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TGFB1—periodontitis	2.98e-05	5.12e-05	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—IL6—periodontitis	2.95e-05	5.08e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL1B—periodontitis	2.94e-05	5.05e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PPARA—periodontitis	2.93e-05	5.05e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—FGF2—periodontitis	2.92e-05	5.03e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—PTGS2—periodontitis	2.91e-05	5.01e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—FGF2—periodontitis	2.91e-05	5e-05	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	2.87e-05	4.94e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NTRK1—periodontitis	2.83e-05	4.88e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.82e-05	4.86e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IFNG—periodontitis	2.81e-05	4.83e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—IL6—periodontitis	2.79e-05	4.81e-05	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—IL6—periodontitis	2.79e-05	4.8e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL1B—periodontitis	2.78e-05	4.78e-05	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—IL6—periodontitis	2.78e-05	4.78e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CCL2—periodontitis	2.78e-05	4.78e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—FGF2—periodontitis	2.77e-05	4.76e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—PTGS2—periodontitis	2.76e-05	4.75e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—FGF2—periodontitis	2.75e-05	4.74e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CXCL8—periodontitis	2.75e-05	4.74e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CCL2—periodontitis	2.75e-05	4.73e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IFNG—periodontitis	2.75e-05	4.73e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IFNG—periodontitis	2.74e-05	4.71e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—NOS2—periodontitis	2.71e-05	4.67e-05	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—IL6—periodontitis	2.65e-05	4.55e-05	CbGpPWpGaD
Nilotinib—HCK—Immune System—IL6—periodontitis	2.64e-05	4.54e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MMP3—periodontitis	2.63e-05	4.53e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CXCL8—periodontitis	2.62e-05	4.51e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IFNG—periodontitis	2.61e-05	4.48e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GGT1—periodontitis	2.55e-05	4.38e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—IL6—periodontitis	2.52e-05	4.33e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—FGF2—periodontitis	2.51e-05	4.32e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL1B—periodontitis	2.5e-05	4.31e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCL2—periodontitis	2.5e-05	4.31e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—MMP9—periodontitis	2.49e-05	4.29e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PPARA—periodontitis	2.49e-05	4.28e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—FGF2—periodontitis	2.48e-05	4.28e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PTGS2—periodontitis	2.48e-05	4.28e-05	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—IL6—periodontitis	2.46e-05	4.24e-05	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—IL6—periodontitis	2.45e-05	4.22e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL1B—periodontitis	2.45e-05	4.22e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL1B—periodontitis	2.44e-05	4.2e-05	CbGpPWpGaD
Nilotinib—HCK—Disease—IL6—periodontitis	2.44e-05	4.2e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—FGF2—periodontitis	2.39e-05	4.12e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL6—periodontitis	2.39e-05	4.12e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL6—periodontitis	2.39e-05	4.12e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL6—periodontitis	2.38e-05	4.1e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCL2—periodontitis	2.37e-05	4.08e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—MMP9—periodontitis	2.37e-05	4.08e-05	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—IL6—periodontitis	2.34e-05	4.02e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL1B—periodontitis	2.32e-05	4e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFB1—periodontitis	2.31e-05	3.98e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—FGF2—periodontitis	2.26e-05	3.89e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	2.25e-05	3.88e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IFNG—periodontitis	2.25e-05	3.88e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—FGF2—periodontitis	2.21e-05	3.8e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CXCL8—periodontitis	2.19e-05	3.78e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CXCL8—periodontitis	2.17e-05	3.74e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GGT1—periodontitis	2.16e-05	3.71e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—FGF2—periodontitis	2.14e-05	3.68e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCL2—periodontitis	2.13e-05	3.67e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFB1—periodontitis	2.11e-05	3.62e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCL2—periodontitis	2.09e-05	3.6e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ACP5—periodontitis	2.08e-05	3.58e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFB1—periodontitis	2.05e-05	3.53e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—IL6—periodontitis	2.02e-05	3.48e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1B—periodontitis	2.01e-05	3.46e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFB1—periodontitis	1.99e-05	3.43e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—PTGS2—periodontitis	1.99e-05	3.43e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MMP9—periodontitis	1.98e-05	3.42e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCL2—periodontitis	1.98e-05	3.41e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CXCL8—periodontitis	1.98e-05	3.4e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MMP9—periodontitis	1.97e-05	3.38e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFB1—periodontitis	1.95e-05	3.36e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—FGF2—periodontitis	1.93e-05	3.32e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL6—periodontitis	1.91e-05	3.28e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTGS2—periodontitis	1.91e-05	3.28e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—FGF2—periodontitis	1.89e-05	3.25e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GGT1—periodontitis	1.88e-05	3.23e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CXCL8—periodontitis	1.87e-05	3.22e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.83e-05	3.16e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PPARA—periodontitis	1.82e-05	3.14e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFB1—periodontitis	1.8e-05	3.09e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—FGF2—periodontitis	1.79e-05	3.08e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MMP9—periodontitis	1.79e-05	3.08e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GGT1—periodontitis	1.77e-05	3.05e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GGT1—periodontitis	1.76e-05	3.02e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—IL6—periodontitis	1.74e-05	3e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL6—periodontitis	1.72e-05	2.96e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCL2—periodontitis	1.71e-05	2.95e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MMP9—periodontitis	1.69e-05	2.92e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CXCL8—periodontitis	1.69e-05	2.9e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CXCL8—periodontitis	1.65e-05	2.84e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFB1—periodontitis	1.64e-05	2.81e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL6—periodontitis	1.63e-05	2.8e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFB1—periodontitis	1.62e-05	2.79e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTGS2—periodontitis	1.62e-05	2.78e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—IL6—periodontitis	1.59e-05	2.73e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CXCL8—periodontitis	1.57e-05	2.7e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—FGF2—periodontitis	1.55e-05	2.66e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL6—periodontitis	1.55e-05	2.66e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PPARA—periodontitis	1.54e-05	2.66e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MMP9—periodontitis	1.53e-05	2.63e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—IL6—periodontitis	1.5e-05	2.59e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MMP9—periodontitis	1.49e-05	2.57e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFB1—periodontitis	1.47e-05	2.54e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL6—periodontitis	1.47e-05	2.53e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL6—periodontitis	1.47e-05	2.52e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFB1—periodontitis	1.44e-05	2.48e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL6—periodontitis	1.44e-05	2.47e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL6—periodontitis	1.43e-05	2.46e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MMP9—periodontitis	1.42e-05	2.44e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFB1—periodontitis	1.4e-05	2.4e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL6—periodontitis	1.36e-05	2.34e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CXCL8—periodontitis	1.35e-05	2.33e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—IL6—periodontitis	1.35e-05	2.33e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PPARA—periodontitis	1.34e-05	2.31e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PPARA—periodontitis	1.27e-05	2.18e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFB1—periodontitis	1.26e-05	2.16e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PPARA—periodontitis	1.26e-05	2.16e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL6—periodontitis	1.23e-05	2.12e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFB1—periodontitis	1.23e-05	2.12e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MMP9—periodontitis	1.22e-05	2.11e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL6—periodontitis	1.22e-05	2.1e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTGS2—periodontitis	1.19e-05	2.04e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL6—periodontitis	1.18e-05	2.02e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFB1—periodontitis	1.17e-05	2.01e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GGT1—periodontitis	1.16e-05	1.99e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL6—periodontitis	1.11e-05	1.91e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—IL6—periodontitis	1.09e-05	1.87e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL6—periodontitis	1.05e-05	1.81e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFB1—periodontitis	1.01e-05	1.74e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTGS2—periodontitis	1e-05	1.73e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL6—periodontitis	9.48e-06	1.63e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL6—periodontitis	9.28e-06	1.6e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL6—periodontitis	8.8e-06	1.51e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTGS2—periodontitis	8.75e-06	1.5e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PPARA—periodontitis	8.29e-06	1.43e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTGS2—periodontitis	8.24e-06	1.42e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTGS2—periodontitis	8.17e-06	1.41e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL6—periodontitis	7.61e-06	1.31e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGS2—periodontitis	5.39e-06	9.27e-06	CbGpPWpGaD
